Route 66 Ventures — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Wellness & FitnessNew York City, US
Aaron Albert(Executive Officer, Director)Mark Groves(Executive Officer)Matthew Sadofsky(Director)
BoardJeff Cantalupo(Director)
Co-investorsSocial StartsTechstarsAble PartnersJoyance PartnersListen VenturesWndrCo
Payzer builds an all-in-one software platform for trade contractors covering payments, financing, and business operations from initial customer contact through final payment.
Construction TechEnterprise SoftwareFintechSaaSCharlotte, US
Joe Giordano(Founder)inDouglas Little(Executive Officer)Joseph A Giordano(Executive Officer, Director)Thomas McCulley(Director)Mark E McDowell(Director)THomas McCulley(Director)
Co-investorsAlerion VenturesElevate Innovation PartnersGray VenturesGrotech VenturesIDEA Fund PartnersCharlotte Fund
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
AI & Machine LearningBiotechDigital HealthMedford, US
Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)
BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)
Co-investorsBonaventure Equity, LLCHatteras Venture PartnersIter InvestmentsMission BiocapitalService Provider CapitalSante Health Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.